Health care in the U.S. is a little like a streaming subscription that keeps raising the price, adds commercials,
and still asks if you’re “still watching.” Except the subscription is your paycheck, your taxes, and the part of
your brain reserved for worrying about surprise bills.

The frustrating part is that health costs don’t rise for just one reason. It’s not simply “too many sick people”
or “too many doctors,” and it’s definitely not because hospitals are handing out free tote bags. U.S. health
spending is pushed up by a mix of high prices, administrative complexity, chronic disease burden, and incentives
that sometimes reward volume over value. The good news: we don’t need 400 complicated answers to start making
progress. We need three clear questionsasked consistently, by everyone who touches the system.

This guide breaks down those three questions and shows how patients, employers, clinicians, and policymakers can
use them to slow spending growth without turning health care into a scavenger hunt for basic services.

Why U.S. health costs keep climbing (and why it feels personal)

In the U.S., health spending has hovered around the high teens as a share of the economyand federal projections
show it trending upward again over the next decade. When health spending grows faster than the economy, the
difference shows up as higher premiums, bigger deductibles, tighter employer budgets, and public programs that
crowd out other priorities. Translation: even if you’re healthy, health costs can still “take a bite” out of your
life.

Here are the big drivers that matter most when you’re trying to slow the growth rate:

• Prices (the “same thing, higher bill” problem): The U.S. often pays more for hospital care,
  physician services, and many procedures than peer countrieseven when utilization isn’t dramatically higher.
  Higher unit prices are a major reason U.S. per-person spending is so high compared to similar nations.
• Volume and intensity (the “more stuff happens” problem): More visits, more imaging, more
  procedures, more specialty care, more follow-ups. Some of this is necessary, some is helpful, and some is
  low-value care that adds cost with little benefit.
• Chronic disease (the “slow-burn budget” problem): Chronic and mental health conditions account
  for a large share of U.S. health spending, and better prevention and management can change long-term cost curves.
• Administrative overhead (the “paperwork is a growth industry” problem): Billing complexity,
  coding, contracting, prior authorization, quality reportingimportant pieces, but often implemented in ways that
  create expensive friction.
• Market power and site of care (the “facility fee surprise” problem): Consolidation and
  vertical integration can raise prices and shift services into higher-cost settings (like hospital outpatient
  departments) even when the clinical service is identical.

So what do we do with that mess? We stop pretending a single silver bullet exists and start forcing better
decisions with three repeatable questions.

The 3 simple questions that slow health costs (without lowering standards)

Question 1: “Does this actually helpright nowfor this person?”

This is the anti-overuse question. It doesn’t mean “deny care.” It means “prove value.”

Overuse happens when tests or treatments provide little or no clinical benefit, don’t change management, or bring
more risk than reward. Sometimes it’s driven by habit (“we always order this panel”), defensive medicine, patient
expectations, or payment incentives. And because health care is a chain reaction, one unnecessary test can lead to
a cascade: incidental findings, more imaging, more consults, more anxiety, and yesmore bills.

A practical way to operationalize this question is to borrow the consumer-friendly approach promoted by
evidence-based “ask before you test” campaigns: clarify necessity, risks, safer options, what happens if you wait,
and the cost implications. Those prompts don’t just protect patients; they reduce low-value utilization that
quietly inflates spending.

Concrete examples where this question saves money and hassle:

• Imaging for uncomplicated low back pain: If there are no red flags (like severe neurologic
  symptoms), early imaging often doesn’t improve outcomes and can lead to unnecessary follow-up.
• Antibiotics for viral illnesses: Costs increase when unnecessary prescriptions trigger side
  effects, return visits, and antibiotic resistance over time.
• Routine pre-op tests for low-risk surgery: “Just in case” testing can be expensive and
  frequently doesn’t change the plan for healthy patients.

How to apply it system-wide: Employers and payers can steer toward high-value care through
coverage policies, clinical decision support, and benefit design that reduces barriers to proven preventive and
primary care. Clinicians can use shared decision-making tools and align ordering habits with current guidelines.
Patients can ask better questionsand get better answersbefore agreeing to the next step.

Question 2: “Where is the best place to do thisand what’s the lowest-cost safe option?”

This is the site-of-care question. The same clinical service can cost dramatically different amounts depending on
where it’s delivered. In many markets, a hospital outpatient department can bill more than an independent clinic
or ambulatory surgery center for the same procedure. Sometimes that higher price reflects added capabilities; other
times it’s simply the “address on the building.”

Two things make this especially important in the U.S.:

• Facility fees and payment differentials: Higher-cost settings can add charges that patients
  don’t expect, and payers pass those costs into premiums.
• Consolidation and vertical integration: When health systems acquire physician practices, care
  can be reclassified as “hospital outpatient,” which may increase allowed amounts and patient cost-sharing.

Concrete examples of “right place, right cost” decisions:

• ER vs urgent care vs telehealth: Many non-emergency issues can be safely handled outside the ER,
  especially with good triage and after-hours primary care access.
• Hospital outpatient vs independent imaging center: For routine imaging, independent centers may
  offer lower negotiated rates depending on local contracts.
• Home health and “hospital at home” models: When clinically appropriate, shifting recovery and
  monitoring into the home can reduce readmissions and avoid higher facility costs.

How to apply it system-wide: Policymakers can reduce wasteful price differentials with
site-neutral payment policies where appropriate. Employers can design networks that reward high-quality, lower-cost
sites (and explain them in plain English). Health systems can expand outpatient and home-based pathways that
improve experience while lowering total cost of care.

Question 3: “What should this costand are we paying in a way that rewards results?”

This is the pricing and incentives question. Even if we deliver the right care in the right place, the system
can still overspend if prices are inflated or if payment models encourage more volume rather than better outcomes.

In the U.S., “the price” is often the least visible part of the experience until the bill arrivesat which point
it becomes the most visible thing you’ve ever seen (printed in 8-point font across 19 pages, of course).
But price matters enormously for cost control, especially in commercial insurance markets where provider prices
can vary widely.

Ways organizations answer “what should it cost?”

• Price transparency and “shoppable services”: When patients and employers can compare negotiated
  rates for common services, it creates pressure to compete on price and convenience.
• Reference-based pricing and caps: Some purchasers set a maximum payment (often tied to a
  benchmark) for routine services, nudging care toward reasonably priced providers.
• Value-based care arrangements: When designed well, these models reward prevention, care
  coordination, and better outcomesnot just more visits.
• Drug strategy: Encouraging generics and biosimilars when appropriate, improving formulary
  transparency, and aligning incentives can reduce pharmacy spend without compromising care.
• Consumer protections: Policies that limit surprise billing and balance billing can reduce
  financial shocks and make costs more predictable.

How to apply it system-wide: Employers can demand better contracting, simplify benefits, and
partner with accountable provider groups. Policymakers can strengthen competition oversight, support payment
reforms that reduce administrative friction, and reduce the conditions that allow extreme price variation for
routine care.

Putting the three questions into action: a simple playbook for real people

The three questions work because they’re usable. You can apply them in a doctor’s office, a benefits meeting, or
a state policy hearing without needing a PhD in actuarial science.

For patients and families: lower costs by improving the “yes”

• Before non-urgent tests or procedures, ask the five basics: Do I need it? What are the risks?
  Are there simpler options? What if I wait? What will it cost me?
• Use primary care like it’s the front door, not the emergency exit: A strong primary care
  relationship can prevent expensive escalations and help you navigate specialist care efficiently.
• Price-shop when it’s safe to do so: Imaging, labs, elective outpatient procedures, and some
  therapies can be “shoppable.” Ask for estimates before scheduling.
• Focus on chronic condition basics that move the needle: Medication adherence, nutrition,
  physical activity, sleep, behavioral health support, and regular check-ins are unglamorousbut they reduce costly
  complications.

For employers and plan sponsors: manage total cost, not just this year’s premium

• Measure what’s driving spend: Musculoskeletal issues, diabetes, cardiovascular disease, cancer,
  and specialty drugs often dominate trend. Identify top cost categories and the “why” behind them.
• Steer to high-value care with smart networks: Tiered networks, centers of excellence for
  complex surgeries, and incentives for lower-cost sites can reduce spending while maintaining quality.
• Remove barriers to the care that prevents bigger bills: Coverage that supports primary care,
  mental health, and evidence-based preventive services can reduce downstream utilization.
• Simplify the member experience: Confusing benefits create delayed care, surprise bills, and
  higher-cost choices. Plain-language benefits aren’t just nicethey’re cost control.

For clinicians and health systems: reduce waste while protecting trust

• Make guideline-aligned care the default: Clinical decision support, order sets, and feedback
  loops can reduce low-value testing without turning visits into arguments.
• Invest in care coordination: Transitions of care (hospital to home, specialist to primary care)
  are a prime source of readmissions and duplicated services.
• Fix the “administrative tax”: Standardize prior authorization rules where possible, reduce
  redundant documentation, and streamline quality reporting to free time for patient care.

For policymakers: make the right decision the easy decision

• Support competition and curb anti-competitive consolidation: Market power can translate into
  higher prices without clear quality gains.
• Reduce site-of-care payment distortions: Paying more for the same service in a higher-cost
  setting pushes spending upward and encourages inefficient care shifts.
• Strengthen transparency and consumer protections: When prices are visible and surprise billing
  is limited, costs become more predictable and manageable.
• Invest in prevention and chronic disease management: Public health and primary care are not
  “extra.” They’re how you avoid paying for preventable complications later.

A quick “three-question” checklist you can reuse tomorrow

If you want something you can literally copy into a Notes app, here it is:

• Does it help? What’s the evidence it improves outcomes for this situation?
• Where should it happen? What’s the safest lower-cost setting for the same service?
• What should it cost? Can we compare prices, and does payment reward results?

Ask these questions often enough and the system has to respondbecause you’ve changed what “normal” looks like.

Conclusion: small questions, big leverage

Slowing health costs doesn’t require guessing which miracle reform will save the day. It requires consistently
improving decisionsone test, one site of care, one contract, one policy at a time.

The three questionsDoes it help? Where’s the best place to do it?
What should it cost?are simple enough to use and strong enough to change behavior. They reduce
low-value care, steer patients to appropriate settings, and bring price discipline into a system that too often
hides it until after the fact.

If you’re a patient, these questions help you avoid unnecessary steps and surprise bills. If you’re an employer,
they help you target the real drivers of medical inflation. If you’re a clinician or policymaker, they help you
build a system where good care is also financially sustainable. In other words: fewer headaches, fewer bills, and
more care that actually matters. That’s a subscription worth keeping.

Experiences from the real world (composite stories) 500+ words

The easiest way to see how these three questions work is to watch what happens when people actually use them.
The following examples are composites based on common, widely reported scenarios in U.S. health care (not
individual, identifiable cases).

1) The “MRI reflex” that turned into a smarter plan

A middle-aged office worker develops back pain after a weekend of ambitious furniture rearranging. At an urgent
care visit, the idea of an MRI comes up quicklybecause it feels like the fastest path to answers. But the patient
asks the first question: “Does this help right now for me?” The clinician explains that without red-flag symptoms,
early imaging often doesn’t change treatment and can uncover incidental findings that lead to more tests. Together,
they agree on a short, structured trial: physical therapy, movement-based rehab, and follow-up if symptoms worsen.

Three weeks later, pain improves, function returns, and no imaging was needed. The cost savings aren’t just the
MRI price. It’s the avoided chain reaction: specialist referrals, repeat imaging, and anxiety-driven care
escalation. The patient still got carejust not the expensive kind that wouldn’t have helped.

2) The “same injection, different building, different bill” surprise

A parent schedules an outpatient infusion appointment for a child’s chronic condition. The medication is covered,
but the bill includes a facility fee that the family didn’t expect. When they ask why, they learn the clinic is
owned by a hospital system and billed as hospital outpatient care. That’s question two in action“Where is the best
place to do this?”

The next time a similar service is needed, the family calls the insurer and asks whether there’s an independent
infusion center or home infusion option in-network. They also ask for a cost estimate before scheduling.
Ultimately, they choose a safe alternative site with lower cost-sharing. The care is the same; the economics are
not. The experience changes how the family approaches future “routine” services, and it also signals to the payer
that steering matters.

3) An employer stops chasing premiums and starts chasing drivers

A regional manufacturing company sees another double-digit premium increase. Historically, leadership responded
by raising deductiblesuntil morale cratered and employees delayed care. This time they apply all three questions.
First: “Does this help?” They analyze claims and find a large share of spending is tied to musculoskeletal pain,
repeat imaging, and surgeries with wide variation in outcomes. Second: “Where should it happen?” They find that
identical outpatient procedures cost far more in hospital outpatient departments than in ambulatory settings.
Third: “What should it cost?” They negotiate a benefit design that rewards high-quality sites and uses a
specialized musculoskeletal program that emphasizes conservative, evidence-based treatment first.

Within a year, the company doesn’t “solve health care,” but trend slows. Employees report clearer navigation, fewer
surprise bills, and faster access to appropriate care. Leadership learns a lesson that applies beyond health
benefits: cost control works best when you improve decisions, not when you simply shift pain onto people who can’t
budget for it.

4) A primary care team uses prevention like a cost-control tool (because it is)

A clinic serving a mixed-income community redesigns how it manages chronic disease. Instead of waiting for
complications, it uses proactive outreach, medication reconciliation, behavioral health integration, and
easy-access follow-ups. Patients with uncontrolled diabetes or hypertension are contacted before they end up in the
ER. This is question one (“Does this help?”) applied to prevention. It’s also question three (“Are we paying for
outcomes?”), because the model works best when payment supports care coordinationnot just face-to-face visits.

Over time, avoidable hospitalizations and readmissions drop. Patients feel supported, and clinicians spend less
time firefighting. The clinic’s experience is a reminder that “cost control” isn’t just cutting; it can be smart
investment in the care that prevents expensive emergencies later.

Across all four stories, the pattern is the same: the three questions create better defaults. They reduce
unnecessary utilization, steer care to appropriate settings, and apply price discipline. And they do it without
asking anyone to accept worse careonly to accept less waste.

The post Slowing health costs requires answering 3 simple questions appeared first on Global Travel Notes.